Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 4, 2023
The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologistsMichael Oertel, Christian Berdel, Gerhard Held, et al.Annals of Hematology|February 25, 2009
Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigensCarsten Zwick, Klaus-Dieter Preuss, Boris Kubuschok, et al.Plos One|July 5, 2013
Bee Venom Phospholipase A2, a Good "Chauffeur" for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1Christine Almunia, Marie Bretaudeau, Gerhard Held, et al.International Journal of Cancer|August 9, 2008
Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cellsGerhard Held, Frank Neumann, Christine Sturm, et al.Cancer Immunology, Immunotherapy : CII|April 27, 2013
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumorsFrank Neumann, Dominic Kaddu-Mulindwa, Thomas Widmann, et al.European Journal of Haematology|September 30, 2020
VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphomaDominic Kaddu-Mulindwa, Maciej Rosolowski, Marita Ziepert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximabJörg Thomas Bittenbring, Frank Neumann, Bettina Altmann, et al.Journal of Cancer Research and Clinical Oncology|February 24, 2009
Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomasCarsten Zwick, Gerhard Held, Vera Hammermeister, et al.Anticancer Research|October 15, 2013
Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free systemGopinadh Jakka, Petra C Schuberth, Markus Thiel, et al.Human Gene Therapy|September 13, 2012
Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trialBoris Kubuschok, Michael Pfreundschuh, Rainer Breit, et al.Pageof 8